Ducommun's stock surged 5.02% during intraday trading on Wednesday, following a series of positive analyst actions.

The rally was driven by multiple Wall Street firms raising their price targets on the company. RBC Capital increased its target to $155 from $150 while maintaining an Outperform rating. Separately, B. Riley lifted its target more significantly to $187 from $155 and reaffirmed a Buy rating on the shares.

These upward revisions reflect growing analyst confidence in Ducommun's prospects, which appears to have spurred investor buying activity during the session.